Precision BioSciences, Inc. | Shareholder Proposal Regarding Quarterly Business Update Calls at Precision BioSciences, Inc.

Status
Omitted
AGM date
Resolution details
Lead filer
Individual
Resolution ask
Adopt or amend a policy
ESG theme
  • Governance
ESG sub-theme
  • Shareholder rights
Filer type
Shareholder
Company HQ country
United States
Resolved clause
That the shareholders of Precision Biosciences, Inc. (the “Company”) request that the Board of Directors adopt a formal policy requiring the Company to host a public webcast or conference call in conjunction with each quarterly and annual earnings release. The call should include prepared remarks from senior management addressing financial performance, operational milestones, and strategic developments, followed by a question‑and‑answer session open to all shareholders and analysts.
Supporting statement
Transparent and consistent communication between management and shareholders is a fundamental principle of good corporate governance. Among publicly traded biotechnology companies, it is a widely adopted practice to host quarterly business update calls in conjunction with earnings releases. These calls promote clarity, accountability, and equal access to information at a time when investors require confidence in both scientific progress and corporate strategy. At present, the Company’s public disclosures surrounding quarterly results are limited to press releases and SEC filings. While these satisfy minimum regulatory obligations, they do not provide the depth of insight that live investor calls offer—especially for emerging and small‑cap biotechnology companies where analyst coverage is limited. A standing quarterly update call would provide important benefits, including: Enhancing transparency and reducing uncertainty. Hearing directly from management provides context behind financial results, program timelines, and strategic priorities. Improving long‑term investor confidence. Regular communication helps stabilize expectations and promotes fair valuation in a sector where information asymmetry can distort market perception. Aligning with peer best practices. The majority of innovative biotechnology companies already conduct quarterly calls. Implementing such a policy positions the Company in line with recognized standards of investor engagement. Minimal cost, high impact. The infrastructure for company webcasts already exists and requires minimal incremental effort relative to the significant goodwill and clarity it provides to shareholders. This proposal does not seek to dictate the specific content or structure of the Company’s communications. Rather, it requests that the Board adopt a policy‑level commitment to hold a call alongside each earnings release, while leaving all operational decisions—including duration, presentation structure, and Q&A format—fully within management’s discretion. Shareholders have a legitimate interest in receiving consistent, equal access to information. A recurring quarterly call reinforces the Company’s commitment to transparent governance, disciplined communication, and a strong relationship with its investor base. For these reasons, shareholders are urged to vote FOR this proposal.

DISCLAIMER: By including a shareholder resolution or management proposal in this database, neither the PRI nor the sponsor of the resolution or proposal is seeking authority to act as proxy for any shareholder; shareholders should vote their proxies in accordance with their own policies and requirements.

Any voting recommendations set forth in the descriptions of the resolutions and management proposals included in this database are made by the sponsors of those resolutions and proposals, and do not represent the views of the PRI.

Information on the shareholder resolutions, management proposals and votes in this database have been obtained from sources that are believed to be reliable, but the PRI does not represent that it is accurate, complete, or up-to-date, including information relating to resolutions and management proposals, other signatories’ vote pre-declarations (including voting rationales), or the current status of a resolution or proposal. You should consult companies’ proxy statements for complete information on all matters to be voted on at a meeting.